5 Most Undervalued Penny Stocks To Buy According To Hedge Funds

4. Organogenesis Holdings Inc. (NASDAQ:ORGO)

Number of Hedge Fund Holders: 15

Organogenesis Holdings Inc. (NASDAQ:ORGO) is a regenerative medicine company. Organogenesis Holdings Inc. (NASDAQ:ORGO) has gained about 7% year to date in 2023. Organogenesis Holdings Inc. (NASDAQ:ORGO) has a PE ratio of 6.14 as of February 5. As of the end of the third quarter of 2022, 15 hedge funds out of the 920 funds tracked by Insider Monkey had stakes in Organogenesis Holdings Inc. (NASDAQ:ORGO). The most significant hedge fund stakeholder in this period was Guy Levy’s Soleus Capital $21 million. The second most significant stakeholder in Organogenesis Holdings Inc. (NASDAQ:ORGO) was Israel Englander’s Millennium Management, with over $4.8 million stake.